Semisynthesis reveals apoptin as a tumour-selective protein prodrug that causes cytoskeletal collapse

Jasmine Wyatt1,2, Yuen Ka Chan1, Mateusz Hess2

  • 1Department of Molecular Oncology, King's College London Guy's Hospital Campus, Hodgkin Building London SE1 1UL UK mahvash.tavassoli@kcl.ac.uk.

Chemical Science
|April 10, 2023
PubMed

Insights

Apoptin protein selectively kills cancer cells by becoming activated through phosphorylation. This process disrupts the cancer cell cytoskeleton, leading to cell death and reduced invasion, offering a new anticancer strategy.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Cell Biology

Background:

  • Apoptin is a viral protein with selective cancer cell-killing properties.
  • Its precise mechanism of action and cancer selectivity remain incompletely understood.
  • Phosphorylation is hypothesized to regulate apoptin's toxicity and selectivity.

Purpose of the Study:

  • To investigate the role of site-specific phosphorylation in apoptin's anticancer activity.
  • To elucidate the molecular mechanisms underlying apoptin's cancer selectivity.
  • To explore the potential of apoptin as a targeted anticancer therapeutic.

Main Methods:

  • Site-specific phosphorylation of apoptin at Thr108 (apoptin-T108ph).
  • Structure-function studies in living cancer cells.
  • Investigation of cellular pathways including actin binding and cytoskeletal integrity.
  • Analysis of anoikis resistance and cancer cell invasion.

Main Results:

  • Thr108 phosphorylation acts as a critical selectivity switch for apoptin toxicity.
  • Phosphorylated apoptin (apoptin-T108ph) binds to actin and disrupts the cytoskeleton.
  • This disruption inhibits anoikis resistance and reduces cancer cell invasion.
  • Apoptin functions as a pro-drug activated by cancer-specific phosphorylation.

Conclusions:

  • Cancer-selective phosphorylation activates apoptin, enhancing its anticancer potency.
  • The mechanism involves cytoskeletal disruption, leading to cancer cell death.
  • This study provides a foundation for developing novel, highly selective protein-based anticancer agents.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
11.7K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.5K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
3.9K
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
12.6K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.9K